TLSI · Company research
TriSalus Life Sciences, Inc. Common Stock (TLSI): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 4.27 | $247,761,021.75 | 201473021.75 | — | — | — | 21.7200860655737705 | 37.8261101908396947 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.